RNS Number : 9099H
IXICO plc
08 May 2025
8 May 2025
IXICO plc
("IXICO", the "Company" or the "Group")
Holding(s) in Company
IXICO plc (the "Company"), announces that it was notified by Amati Global Investors Limited on 6 May 2025 that, as of 1 May 2025, the Investment Manager of Amati AIM VCT plc changed from Amati Global Investors Limited to Maven Capital Partners UK LLP, following which the name of the shareholder changed from Amati AIM VCT plc to Maven Renovar VCT plc. There has been no change to the position held in the Company.
Further information concerning the notification of major holdings is provided below.
Ends
Further information:
IXICO plc
+44 (0) 20 3763 7499
Bram Goorden, Chief Executive Officer Grant Nash, Chief Financial Officer
Cavendish Capital Markets Limited(Nominated Adviser and Sole Broker)
+44 (0) 20 7220 0500
Giles Balleny / Dan Hodkinson (Corporate Finance) Nigel Birks (Life Science Specialist Sales) Harriet Ward (Corporate Broking) Michael F Johnson / Tamar Cranford Smith (Sales)
About IXICO www.IXICO.com
IXICO is dedicated to delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Parkinson's disease and Alzheimer's disease. The Company's purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience by supporting pharmaceutical companies across all phases of CNS clinical research. IXICO's goal is to be a leading advocate of artificial intelligence in medical image analysis.
IXICO has developed and deployed breakthrough data analytics, at scale, through its remote access technology platform, to improve the return on investment in drug development and reduce risk and uncertainty in clinical trials for the Company's pharmaceutical clients.
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BFXR4C20
Issuer Name
IXICO PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
Other
Comments
Please refer to the Additional Information section below. There has been no change to the position held in the Issuer.
3. Details of person subject to the notification obligation
Name
Amati Global Investors Limited
City of registered office (if applicable)
Edinburgh
Country of registered office (if applicable)
United Kingdom
4. Details of the shareholder
Name
City of registered office
Country of registered office
Maven Renovar VCT plc
London
United Kingdom
5. Date on which the threshold was crossed or reached
01-May-2025
6. Date on which Issuer notified
06-May-2025
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A)
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached
0.000000
0.000000
0.000000
0
Position of previous notification (if applicable)
9.830000
0.000000
9.830000
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)
Number of direct voting rights (DTR5.1)
Number of indirect voting rights (DTR5.2.1)
% of direct voting rights (DTR5.1)
% of indirect voting rights (DTR5.2.1)
GB00BFXR4C20
0
0
0.000000
0.000000
Sub Total 8.A
0
0.000000%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument
Expiration date
Exercise/conversion period
Number of voting rights that may be acquired if the instrument is exercised/converted
% of voting rights
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument
Expiration date
Exercise/conversion period
Physical or cash settlement
Number of voting rights
% of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification obligation
1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
Ultimate controlling person
Name of controlled undertaking
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
On 1st May 2025 the Investment Manager of Amati AIM VCT plc (the "Company") changed from Amati Global Investors Limited to Maven Capital Partners UK LLP, following which the name of the Company changed from Amati AIM VCT plc to Maven Renovar VCT plc. There has been no change to the position held in the Issuer.
12. Date of Completion
06-May-2025
13. Place Of Completion
Edinburgh, UK
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLAPMMTMTTMBRA
